Skip to main content

Falcon Technologies, Inc


Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) OTC:FLCN is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019.

Company Website:  Under Construction

Security Details

Authorized Shares:        100,000,000

Outstanding Shares        19,531,847

Float                                    5,086,101

Information from OTC Markets 

The Opportunity

The CBD industry will quickly become a Multi-Billion Dollar sector in short order.   Investing in early stage companies that are positioning themselves to capture a part of this market is a wise investment for future high returns.  FLCN is one of those companies.   The strategic direction of FLCN will position the business in a very profitable situation based on early projections.    We believe that an investment at this level could return exponential gains over the next few months and definitely the next few years.   We encourage you to do your own due diligence on this exciting company.   

In the NEWS

Falcon Technologies Comments on CVS Now Selling CBD Products in Select Stores in the United StatesPress Release | 04/17/2019

SACRAMENTO, CA / ACCESSWIRE / April 17, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN), a company focusing on the marketing, sale, and distribution of CBD products and products derived from industrial hemp such as protein powder, hemp seeds and hemp oil has commented on the recent news that CVS began selling topical CBD products.

Universally known as CBD, Cannabidiol (the scientific name for CBD) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties.

The 2018 Farm Bill legalized industrial hemp, removing this plant rich in CBD and nutritional supplements from the Controlled Substance Act and categorizing it as an agricultural commodity. This bill will allow states to regulate hemp farming while moving the industrialization of the hemp plant forward. As industrial hemp once again becomes one of America's most popular agricultural crops, the amount of CBD processed from the plant will grow exponentially. The hemp-CBD market is projected to grow from $600 million in 2018 to $22 billion by 2022.

Over the past week, CVS, one of North America's largest drug store chains began selling topical CBD products. In an interview with CNBC's Jim Cramer, CVS CEO Larry Merlo commented on CVS now selling CBD products, "We're going to be carrying them in 8 states. We're going to be carrying the topical products only. " Merlo added, "Anecdotally, we've heard from our customers that have used those products, it's helped for pain relief, arthritis and other ailments. We're going to walk slowly but we think this is something the customers are going to be looking for as part of the health offering."

William Delgado, Chairman and Chief Executive Officer of Falcon Technologies commented, "We applaud CVS's entry into the CBD market. Several weeks ago, we announced that we filed a provisional patent application titled "CBD Formulations to Treat Acne". We are also working diligently behind the scenes to create CBD formulations for other skin conditions."

Delgado added, "It is critically important that our shareholders and investors understand we are one step ahead. The whole world is focusing on CBD topical formulations for pain. We believe it goes well beyond that and we will be announcing additional progress and CBD topical formulations over the next few weeks and months."

Falcon Technologies Announces the Signing of an Exclusive 2 Year Worldwide License with Publicly-Traded Stevia Corp. to Sell, Market, and Distribute Hemp Products Using the Real Hemp(TM) Brand with an Option to PurchasePress Release | 04/10/2019

SACRAMENTO, CA / ACCESSWIRE / April 10, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) (OTC PINK: STEV) announced today that it has signed an exclusive worldwide license to use the Real Hemp trademark and brand to market, sell and distribute any dietary and nutritional supplements containing any constituents of the hemp plant for the next 2 years. As part of this license, Falcon Technologies will have an option to buy the trademark and all the rights to the brand during the license term. As a result of the vision of Stevia Corp.'s Chairman George Blankenbaker, Real Hemp LLC (Stevia Corp.'s wholly owned subsidiary), achieved trademark status and full trademark registration on July 7, 2015 before the cultivation of hemp products became completely legal in the United States.

The licensing agreement will provide Falcon with exclusive rights to use all product images, design, and graphics, product packaging, any existing social media accounts, any related printed, electronic, and online documentation, any graphic files for product packaging, and any software files that may accompany the product.

Up until a few short months ago, most hemp products on shelves in the United States were imported into the United States. However, the 2018 Farm Bill legalized the cultivation of industrial hemp and removed it from the list of controlled substances.

Industrial hemp contains all of the cannabinoids in medical marijuana but unlike marijuana, industrial hemp is low in THC (tetrahydrocannabinol - the psychoactive component in marijuana). Some strains of industrial hemp are also rich in CBD (cannabidiol), the cannabinoid which has been featured in hundreds of news stories for its therapeutic potential to potentially treat serious medical ailments such as epilepsy, cancer, pain, arthritis, and many others.

The hemp seed and the oil derived from the seed is an excellent source of protein and essential fatty acids. Three tablespoons of hemp seeds contain about 10 grams of protein. The protein from the hemp plant is a more complete protein than proteins found in red meat, chicken and fish. Hemp seeds are sold in national health food and supplements retailers. The stalk of the hemp plant contains two types of fiber. The outer fiber can be processed into long strands which can then be used for textile manufacturing. The inner core which resembles wood can be used for animal bedding. The hemp stalk can also be used as a key component in the manufacturing of paper.

There are few dominant hemp product brands in North America today. Stevia Corp. has worked tirelessly to build the Real Hemp brand and trademark for the past 3 years. Led by George Blankenbaker who served as Vice President and Director of the U.S. Hemp Roundtable and was a founding member, Director and Vice President of the U.S. Hemp Farming Alliance and a longtime member of the Hemp Industries Association, the Real Hempbrand is perfectly positioned to become a leader in the hemp products market which is expected to grow exponentially in the United States now that the cultivation of hemp is legal throughout the United States.

William J. Delgado, Chairman and Chief Executive Officer of Falcon Technologies commented, ''We are beyond ecstatic that Stevia Corp. has given us this vote of confidence to license the exclusive rights to use the Real Hempbrand for the next 2 years. George and his team have done a fantastic job in building the Real Hemp brand which we believe has the potential to be the number 1 hemp products brand in the United States.''

George Blankenbaker, Chairman and Chief Executive Officer of Stevia Corp. said, ''This is a win-win for both companies. If the result is what both companies believe the result can potentially be, Falcon will own a leading brand representing quality and health in a fast emerging market generating millions in revenue while enabling Stevia Corp. to become debt free as a result of the licensing royalty payments and potential outright purchase of the brand.''